Capital International Inc. CA increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 58.6% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 96,156 shares of the medical device company’s stock after acquiring an additional 35,539 shares during the period. Capital International Inc. CA’s holdings in Cooper Companies were worth $6,592,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of COO. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies during the second quarter worth approximately $36,000. MUFG Securities EMEA plc acquired a new stake in Cooper Companies in the second quarter valued at approximately $42,000. Assetmark Inc. increased its position in shares of Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after buying an additional 483 shares in the last quarter. Quent Capital LLC purchased a new stake in shares of Cooper Companies in the third quarter valued at approximately $44,000. Finally, Mather Group LLC. acquired a new position in shares of Cooper Companies during the 3rd quarter worth approximately $56,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Insider Buying and Selling at Cooper Companies
In other Cooper Companies news, CEO Albert G. White III purchased 10,000 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The shares were purchased at an average cost of $80.80 per share, with a total value of $808,000.00. Following the completion of the purchase, the chief executive officer owned 236,151 shares in the company, valued at approximately $19,081,000.80. This represents a 4.42% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Cynthia L. Lucchese purchased 1,784 shares of the stock in a transaction that occurred on Monday, December 22nd. The shares were acquired at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the transaction, the director directly owned 9,445 shares of the company’s stock, valued at $793,946.70. The trade was a 23.29% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have bought 16,014 shares of company stock valued at $1,304,416. 2.08% of the stock is owned by company insiders.
Analysts Set New Price Targets
Read Our Latest Stock Report on COO
Cooper Companies Stock Performance
Shares of NASDAQ:COO opened at $73.75 on Thursday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The business’s 50 day moving average price is $81.66 and its 200-day moving average price is $76.00. The firm has a market capitalization of $14.39 billion, a PE ratio of 36.51, a P/E/G ratio of 1.92 and a beta of 1.02. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Stories
- Five stocks we like better than Cooper Companies
- The gold chart Wall Street is terrified of…
- “This AI Giant is About to Go Bust”
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
